FindTrial
Sign In

A study designed to understand the reaction of a device inserted into the vein and to know the occurrence of blood clot inside the vein due to the device

Incidence of fibroblastic sleeve and catheter related thrombosis with novel mid-clavicular midline catheters - A prospective longitudinal observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036967
Enrollment
50
Registered
2021-09-29
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Mahatma Gandhi Medical College and Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients requiring intermediate vascular access in the ward

Exclusion criteria

Exclusion criteria: Patients with prior history of upper extremity thrombosis Patients on oral contraceptive pills Critically ill patients Pregnant patients Patients who have undergone bilateral mastectomy Infection at device insertion site

Design outcomes

Primary

MeasureTime frame
Incidence of fibroblastic sleeve and catheter related thrombosisTimepoint: On alternate days of catheter insertion post catheter insertion—

Secondary

MeasureTime frame
Correlation between demographics, procedural details and medication administered with incidence of fibroblastic sleeve and catheter related thrombosisTimepoint: At the end of the data collection;Patient demographic details Number of attempts at cannulation Position of catheter tipTimepoint: At the time of device insertion—

Countries

India

Contacts

Public ContactDr Charulatha R

Mahatma Gandhi Medical College and Research Institute

ravindrancharulatha@gmail.com9894909652

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026